Alerts will be sent to your verified email
Verify Email
KILITCH
|
Kilitch Drugs(India)
|
Sakar Healthcare
|
Ind-Swift Lab.
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
4.81 % | 9.28 % | 9.6 % |
|
5yr average Equity Multiplier
|
1.42 | 1.75 | 2.49 |
|
5yr Average Asset Turnover Ratio
|
0.51 | 0.5 | 0.67 |
|
5yr Avg Net Profit Margin
|
6.07 % | 10.38 % | 6.7 % |
|
Price to Book
|
3.74 | 2.54 | 0.69 |
|
P/E
|
26.98 | 36.67 | 3.52 |
|
5yr Avg Cash Conversion Cycle
|
-7.56 Days | -14.29 Days | 76.78 Days |
|
Inventory Days
|
17.9 Days | 46.75 Days | 126.74 Days |
|
Days Receivable
|
138.92 Days | 51.16 Days | 95.44 Days |
|
Days Payable
|
199.26 Days | 103.34 Days | 94.9 Days |
|
5yr Average Interest Coverage Ratio
|
5.07 | 5.43 | 3.49 |
|
5yr Avg ROCE
|
8.16 % | 10.08 % | 12.63 % |
|
5yr Avg Operating Profit Margin
|
9.07 % | 24.06 % | 19.31 % |
|
5 yr average Debt to Equity
|
0.14 | 0.47 | 1.22 |
|
5yr CAGR Net Profit
|
77.02 % | 3.94 % | n/a |
|
5yr Average Return on Assets
|
3.38 % | 5.37 % | 7.66 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
69.23 % | 52.86 % | 40.94 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.98 % | -14.68 % | -1.06 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Kilitch Drugs(India)
|
Sakar Healthcare
|
Ind-Swift Lab.
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|